Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?

× No keyword cloud information.

10 in total

1. Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".

Authors: Avivit Cahn; Eytan Roitman; Genya Aharon-Hananel; Itamar Raz
Journal: Endocrine Date: 2016-12-30 Impact factor: 3.633

2. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats.

Authors: Kai Pan; Xiaolei Shi; Kai Liu; Ju Wang; Yijun Chen
Journal: Drug Des Devel Ther Date: 2021-08-10 Impact factor: 4.162

3. Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer.

Authors: Divya Sharma; Jagdish Singh
Journal: J Control Release Date: 2020-04-10 Impact factor: 9.776

4. Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.

Authors: Vincent J Willey; Sheldon Kong; Bingcao Wu; Amit Raval; Todd Hobbs; Andrea Windsheimer; Gaurav Deshpande; Ozgur Tunceli; Brian Sakurada; Jonathan R Bouchard
Journal: Am Health Drug Benefits Date: 2018-09

Review 5. Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability.

Authors: A K J Gradel; T Porsgaard; J Lykkesfeldt; T Seested; S Gram-Nielsen; N R Kristensen; H H F Refsgaard
Journal: J Diabetes Res Date: 2018-07-04 Impact factor: 4.011

6. Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study.

Authors: Mizuho Yamabe; Mami Kuroda; Yasuyo Hirosawa; Hiromi Kamino; Haruya Ohno; Masayasu Yoneda
Journal: J Diabetes Investig Date: 2018-08-06 Impact factor: 4.232

Review 7. A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.

Authors: Thomas Forst; Pratik Choudhary; Doron Schneider; Bruno Linetzky; Paolo Pozzilli
Journal: Diabetes Metab Res Rev Date: 2020-12-01 Impact factor: 4.876

8. Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.

Authors: Brian Godman; Magdalene Wladysiuk; Stuart McTaggart; Amanj Kurdi; Eleonora Allocati; Mihajlo Jakovljevic; Francis Kalemeera; Iris Hoxha; Anna Nachtnebel; Robert Sauermann; Manfred Hinteregger; Vanda Marković-Peković; Biljana Tubic; Guenka Petrova; Konstantin Tachkov; Juraj Slabý; Radka Nejezchlebova; Iva Selke Krulichová; Ott Laius; Gisbert Selke; Irene Langner; András Harsanyi; András Inotai; Arianit Jakupi; Svens Henkuzens; Kristina Garuolienė; Jolanta Gulbinovič; Patricia Vella Bonanno; Jakub Rutkowski; Skule Ingeberg; Øyvind Melien; Ileana Mardare; Jurij Fürst; Sean MacBride-Stewart; Carol Holmes; Caridad Pontes; Corinne Zara; Marta Turu Pedrola; Mikael Hoffmann; Vasileios Kourafalos; Alice Pisana; Rita Banzi; Stephen Campbell; Bjorn Wettermark
Journal: Biomed Res Int Date: 2021-10-11 Impact factor: 3.411

9. Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials.

Authors: M H Cummings; D Cao; I Hadjiyianni; L L Ilag; M H Tan
Journal: Clin Diabetes Endocrinol Date: 2018-05-08

10. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.

Authors: Lori Berard; Noreen Antonishyn; Kathryn Arcudi; Sarah Blunden; Alice Cheng; Ronald Goldenberg; Stewart Harris; Shelley Jones; Upender Mehan; James Morrell; Robert Roscoe; Rick Siemens; Michael Vallis; Jean-François Yale
Journal: Diabetes Ther Date: 2018-02-23 Impact factor: 2.945

10 in total